Hand-out
Press Releases
EISAI PRESENTS LATEST CLINICAL FINDINGS SUGGESTING INHIBITION OF TAU PROPAGATION BY ANTI-MTBR TAU ANTIBODY E2814 AT THE 17TH CLINICAL TRIALS ON ALZHEIMER’S DISEASE CONFERENCE (CTAD)
-Eisai Initiates Phase II Clinical Study on Sporadic Early Alzheimer's Disease-